U.S. Long Read Sequencing Market Size & Outlook, 2023-2030
U.S. long read sequencing market, 2018-2030 (US$M)
Related Markets
U.S. long read sequencing market highlights
- The U.S. long read sequencing market generated a revenue of USD 272.8 million in 2023 and is expected to reach USD 1,777.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 30.7% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Long read sequencing market data book summary
| Market revenue in 2023 | USD 272.8 million |
| Market revenue in 2030 | USD 1,777.5 million |
| Growth rate | 30.7% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Pacific Biosciences of California Inc, Oxford Nanopore Technologies PLC, Eurofins Scientific SE, Roche Holding AG ADR, New England Biolabs, Huawei Technologies, BGI Group, Quantapore, Element Biosciences, MicrobesNG |
Other key industry trends
- In terms of revenue, U.S. accounted for 47.6% of the global long read sequencing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. long read sequencing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 153.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Long Read Sequencing Market Scope
Long Read Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. long read sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to long read sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 62.68% in 2023. Horizon Databook has segmented the U.S. long read sequencing market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Long Read Sequencing Product Outlook (Revenue, USD Million, 2018-2030)
- Instruments
- Consumables
- Services
- U.S. Long Read Sequencing Technology Outlook (Revenue, USD Million, 2018-2030)
- Single Molecule Real Time Sequencing
- Nanopore Sequencing
- Others
- U.S. Long Read Sequencing Workflow Outlook (Revenue, USD Million, 2018-2030)
- Pre-sequencing
- Sequencing
- Data Analysis
- U.S. Long Read Sequencing Application Outlook (Revenue, USD Million, 2018-2030)
- Whole Genome Sequencing
- Targeted Sequencing
- Metagenomics
- RNA Sequencing
- Epigenetics
- Others
- U.S. Long Read Sequencing End Use Outlook (Revenue, USD Million, 2018-2030)
- Academic & Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Reasons to subscribe to U.S. long read sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. long read sequencing market databook
-
Our clientele includes a mix of long read sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. long read sequencing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. long read sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. long read sequencing market size, by product, 2018-2030 (US$M)
U.S. Long Read Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
